Why Your Pre-Bed HGH Injection Is Built For The Wrong Body

Your body already makes growth hormone every night whether you inject or not, and that single fact changes everything about when you should be timing your dose.

Here is the full chain before we zoom into any one piece of it. Growth hormone gets released from a gland in your brain called the pituitary, it travels to your liver, and your liver converts it into something called IGF-1, which is insulin-like growth factor 1, the actual molecule that drives muscle growth, fat metabolism, and tissue repair. The growth hormone itself is not doing the heavy lifting directly. It is the IGF-1 that does. So the whole game is about how much IGF-1 you produce from the growth hormone you are putting in, and that conversion depends on when your liver is primed to do the job.

Now zoom in on the sleep piece.

During the deep stages of slow-wave sleep, your pituitary releases somewhere around 70 percent of your total daily growth hormone output in a single concentrated pulse. This is not a trickle across the night. It is one large surge happening in the first few hours after you fall asleep, and it is free. Your body is running this program every night without any pharmaceutical input at all.

So when someone pins subcutaneous HGH at 10 pm, the pharmacokinetics of a subcutaneous injection mean that blood levels peak roughly 4 hours after the shot. That puts the peak at 2 in the morning, sitting right on top of the pulse your pituitary is already producing. You are not adding to an empty bucket. You are flooding a bucket that is already filling on its own.

Growth hormone is counter-regulatory to insulin, which means it works against insulin at the level of the liver and peripheral tissues. Think of insulin as one pedal and growth hormone as the other. When growth hormone is high, your liver backs away from insulin's signals, glucose output from the liver rises, and blood sugar climbs. This is the mechanism behind what researchers call the dawn phenomenon, where overnight growth hormone spikes cause a measurable drop in hepatic insulin sensitivity by morning in people with type 1 diabetes. Running exogenous HGH into that same overnight window amplifies exactly this effect, which is why people who pin at night often wake up with elevated fasting glucose and a grogginess they cannot explain. The groggy feeling is a downstream effect of dysregulated overnight blood sugar, not some coincidence.

Now here is the conversion piece that most people never account for.

Your liver's ability to convert growth hormone into IGF-1 is not constant across the day. The liver needs insulin signaling to facilitate that conversion efficiently. When you are fasted, insulin is low, and IGF-1 production from any given amount of growth hormone is blunted. When a meal arrives and insulin rises, the liver becomes significantly more responsive to growth hormone and the conversion rate climbs.

This creates a window. If you inject growth hormone in the fasted morning state and then eat a real meal 30 to 60 minutes later, your blood levels of growth hormone are climbing during the fasted window and then peak while insulin is rising from that first meal. The two signals land at the liver at the same time, which is when IGF-1 output is highest. You are pairing the substrate with the co-factor. One without the other leaves efficiency on the table.

At doses of 4 IU or more per day, a single morning injection cannot sustain meaningful IGF-1 production across a full 24 hours because growth hormone has a relatively short half-life in circulation. So the approach is to split the dose, one injection fasted in the morning and a second injection in the late afternoon, which again falls before another meal. You maintain IGF-1 production through the day without compressing either dose into the overnight window where your own pituitary is already doing the work and where counter-regulatory effects on blood sugar are most disruptive.

The pre-bed protocol has a specific origin worth understanding.

The 1990 study by Jorgensen and colleagues that is often cited as the basis for nighttime injections was conducted on GH-deficient patients, people whose pituitaries had stopped producing growth hormone entirely. They had no endogenous pulse to interfere with. When the researchers compared evening versus morning injections in this population, 24-hour IGF-1 levels came out essentially the same between groups. There was no meaningful difference.

That finding makes sense when you understand why. In GH-deficient patients the overnight bucket is empty. Pinning at night fills it. Pinning in the morning fills it at a different time. The liver conversion efficiency differences were not large enough to separate the groups when there was no endogenous pulse causing interference. The study was never designed for and never tested on people with functional pituitary output. Applying its conclusions to a healthy person running exogenous HGH is like using data from patients with no stomach acid to guide recommendations for people whose acid production is normal.

The counter-regulatory glucose effect is also more than a comfort issue. Moller and Jorgensen's 2009 review of growth hormone's effects on glucose, lipid, and protein metabolism makes clear that chronic elevation of growth hormone suppresses glucose uptake in peripheral tissues and drives hepatic glucose output, and that these effects are dose and timing dependent. Running that signal overnight, on top of your own pulse, and without the insulin co-factor needed for IGF-1 conversion, means you are getting the metabolic cost without optimizing the anabolic return.

The morning fasted window with a meal 30 to 60 minutes later targets the opposite set of conditions. Low background growth hormone from the previous night's natural pulse having cleared, no competing endogenous signal, insulin arriving at the right time to facilitate conversion, and the overnight pulse left completely undisturbed to run its own program.

The pre-bed protocol was built for a body that had lost its pituitary function. If yours still works, the timing was never designed for you.

---

References

1. Van Cauter E, Plat L. (1996). Physiology of growth hormone secretion during sleep. J Pediatr 128(5 Pt 2):S32-37. DOI: 10.1016/s0022-3476(96)70008-2
2. Jorgensen JO, Moller N, Moller J, Weeke J, Christiansen JS. (1985). Pharmacokinetics of biosynthetic authentic human growth hormone in normal men after subcutaneous or intramuscular injection. Acta Endocrinol (Copenh). PMID: 4034296
3. Jorgensen JO, Moller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS. (1990). Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 70(1):207-14. PMID: 2294131. DOI: 10.1210/jcem-70-1-207
4. Moller N, Jorgensen JO. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152-77. PMID: 19240267. DOI: 10.1210/er.2008-0027
5. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. (1990). Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33(1):52-9. PMID: 2406181. DOI: 10.1007/BF00586461

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness